Brief: Caris Life Sciences Announces Preliminary Fourth Quarter And Full Year 2025 Results
12/01/2026 13:34
Jan 12 (Reuters) - Caris Life Sciences Inc CAI.O: CARIS LIFE SCIENCES ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 RESULTS PRELIM FULL YEAR REVENUE $800 MILLION FY2025 REVENUE VIEW $724.4 MILLION -- LSEG IBES DATA Source text: ID:nPn8VTpkGa Further company coverage: CAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caris Life Sciences
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Caris Life Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services